CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells

Succinylation modification involves in the progression of human cancers. The present study aimed to investigate the role of CPT1A, which is a succinyltransferase in the progression of prostate cancer (PCa). CCK-8 was used to detect the cell viability. Seahorse was performed to evaluate the cell glyc...

Full description

Saved in:
Bibliographic Details
Main Authors: Shufeng Liu, Xiaoguang Chen, Liqi Zhang, Bo Lu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Cancer Biology & Therapy
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15384047.2024.2329372
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850248005549031424
author Shufeng Liu
Xiaoguang Chen
Liqi Zhang
Bo Lu
author_facet Shufeng Liu
Xiaoguang Chen
Liqi Zhang
Bo Lu
author_sort Shufeng Liu
collection DOAJ
description Succinylation modification involves in the progression of human cancers. The present study aimed to investigate the role of CPT1A, which is a succinyltransferase in the progression of prostate cancer (PCa). CCK-8 was used to detect the cell viability. Seahorse was performed to evaluate the cell glycolysis. Luciferase assay was used to detect the transcriptional regulation. ChIP was performed to assess the binding between transcriptional factors with the promoters. Co-IP was used to assess the binding between proteins. We found that CPT1A was highly expressed in PCa tissues and cell lines. Silencing of CPT1A inhibited the viability and glycolysis of PCa cells. Mechanistically, CPT1A promoted the succinylation of SP5, which strengthened the binding between SP5 and the promoter of PDPK1. SP5 activated PDPK1 transcription and PDPK1 activated the AKT/mTOR signal pathway. These findings might provide novel targets for the diagnosis or therapy of prostate cancer.
format Article
id doaj-art-cb5ecdfdd8e545689f50e93157a10ffb
institution OA Journals
issn 1538-4047
1555-8576
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Cancer Biology & Therapy
spelling doaj-art-cb5ecdfdd8e545689f50e93157a10ffb2025-08-20T01:58:48ZengTaylor & Francis GroupCancer Biology & Therapy1538-40471555-85762024-12-0125110.1080/15384047.2024.2329372CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cellsShufeng Liu0Xiaoguang Chen1Liqi Zhang2Bo Lu3Medical Department, Xiangyang Integrated Traditional and Western Medicine Hospital, Xiangyang, Hubei, ChinaUrology Department, Xiangyang Integrated Traditional and Western Medicine Hospital, Xiangyang, Hubei, ChinaLaboratory Department, Xiangyang Integrated Traditional and Western Medicine Hospital, Xiangyang, Hubei, ChinaLaboratory Department, Xiangyang Integrated Traditional and Western Medicine Hospital, Xiangyang, Hubei, ChinaSuccinylation modification involves in the progression of human cancers. The present study aimed to investigate the role of CPT1A, which is a succinyltransferase in the progression of prostate cancer (PCa). CCK-8 was used to detect the cell viability. Seahorse was performed to evaluate the cell glycolysis. Luciferase assay was used to detect the transcriptional regulation. ChIP was performed to assess the binding between transcriptional factors with the promoters. Co-IP was used to assess the binding between proteins. We found that CPT1A was highly expressed in PCa tissues and cell lines. Silencing of CPT1A inhibited the viability and glycolysis of PCa cells. Mechanistically, CPT1A promoted the succinylation of SP5, which strengthened the binding between SP5 and the promoter of PDPK1. SP5 activated PDPK1 transcription and PDPK1 activated the AKT/mTOR signal pathway. These findings might provide novel targets for the diagnosis or therapy of prostate cancer.https://www.tandfonline.com/doi/10.1080/15384047.2024.2329372Prostate cancerCPT1ASP5PDPK1succinylationtranscription
spellingShingle Shufeng Liu
Xiaoguang Chen
Liqi Zhang
Bo Lu
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells
Cancer Biology & Therapy
Prostate cancer
CPT1A
SP5
PDPK1
succinylation
transcription
title CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells
title_full CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells
title_fullStr CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells
title_full_unstemmed CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells
title_short CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells
title_sort cpt1a mediates the succinylation of sp5 which activates transcription of pdpk1 to promote the viability and glycolysis of prostate cancer cells
topic Prostate cancer
CPT1A
SP5
PDPK1
succinylation
transcription
url https://www.tandfonline.com/doi/10.1080/15384047.2024.2329372
work_keys_str_mv AT shufengliu cpt1amediatesthesuccinylationofsp5whichactivatestranscriptionofpdpk1topromotetheviabilityandglycolysisofprostatecancercells
AT xiaoguangchen cpt1amediatesthesuccinylationofsp5whichactivatestranscriptionofpdpk1topromotetheviabilityandglycolysisofprostatecancercells
AT liqizhang cpt1amediatesthesuccinylationofsp5whichactivatestranscriptionofpdpk1topromotetheviabilityandglycolysisofprostatecancercells
AT bolu cpt1amediatesthesuccinylationofsp5whichactivatestranscriptionofpdpk1topromotetheviabilityandglycolysisofprostatecancercells